Product proliferation and consumer demand create challenges for retailers at the shelf where room must be made for new Rx-to-OTC items
Rx-to-OTC switches in the stomach care category bring additional sales, but they can sometimes be hard for food retailers to digest, given restricted shelf space. A potential new entry to watch is the heartburn treatment drug Zegerid, from Shering-Plough Corp., Kenilworth, N.J. The drug maker applied this year to the U.S. Food and Drug Administration for a new drug application for an OTC low-dose version. Perrigo, Allegan, Mich., began shipping Omeprazole, a store-brand heartburn remedy ...
SIGN IN TO ACCESS THIS ARTICLE
Registering for Premium Content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick.